For the year ending 2025-12-31, OCGN made $4,413K in revenue. -$67,846K in net income. Net profit margin of -1537.41%.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Total revenue | 4,413 | |||
| Research and development | 39,750 | |||
| General and administrative | 27,579 | |||
| Total operating expenses | 67,329 | |||
| Loss from operations | -62,916 | |||
| Interest income | 922 | |||
| Interest expense | 5,188 | |||
| Other (expense) income, net | -664 | |||
| Total other (expense) income | -4,930 | |||
| Net loss | -67,846 | |||
| Net loss attributable to shareholders - basic | -67,846 | |||
| Net loss attributable to shareholders - diluted | -67,846 | |||
| Basic EPS | -0.23 | |||
| Diluted EPS | -0.23 | |||
| Basic Average Shares | 300,167,989 | |||
| Diluted Average Shares | 300,167,989 | |||
Ocugen, Inc. (OCGN)
Ocugen, Inc. (OCGN)